Additionally, it can provide cardio protection for people with diabetes
A new study has found the new oral pill GLP-1 medication elecoglipron may help to significantly reduce blood sugar levels and body weight in people with type 2 diabetes
Triple-Action Mechanism Most GLP-1 receptor agonists, like Semaglutide and Tirzepatide, target one or two receptors in the body that regulate appetite and metabolism
While semaglutide does not directly cause anxiety in most people, the combination of rapid dietary changes, blood sugar fluctuations, and reduced caloric intake can trigger these symptoms
As with any medical treatment, GLP-1 may cause certain side effects such as: abdominal pain, headache, low blood sugar, constipation, fatigue, nausea, vomiting, diarrhea, dizziness and acid reflux
What did the SELECT study show